Market recovers; Yes Bank top gainer
Market recovers; Yes Bank top gainer

Market recovers; Yes Bank top gainer

Gayathri Udyawar Article rating: 4.7

The Indian benchmark indices closed with gains despite experiencing volatile trade on Tuesday. Yes Bank was the top gainers on both the benchmarks Sensex and Nifty. Broader markets also participated in the rally with Mid-cap and Small-cap indices gaining more than 1 per cent.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Shital Jibhe Article rating: 3.5

The markets on Dec 11, 2018 opened gap up. BSE Sensex is trading at 35,060.86 up by 101.14 points and the Nifty is trading at 10,521 up by 28.20 points. 

Dr Reddys launches heartburn OTC tablet in US
Dr Reddys launches heartburn OTC tablet in US

Dr Reddys launches heartburn OTC tablet in US

Gayathri Udyawar Article rating: 5.0

The pharma major launched omeprazole delayed-release tablets, 20 mg, an over-the-counter (OTC) equivalent of Prilosec OTC in the US market. This has helped the stock trade in the green in an otherwise volatile market on Tuesday.

Rupee down by 1.6 per cent, bonds skid
Rupee down by 1.6 per cent, bonds skid

Rupee down by 1.6 per cent, bonds skid

Aakash Makhija Article rating: 5.0
The rupee and bonds plunged as Reserve Bank of India Governor, Urjit Patel resigned post market hours on Monday, surprising many investors. Concerns about mixed results from crucial state elections also kept traders wary during Tuesday's trading session.
Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 78, 93,174 contracts with a turnover of Rs. 4, 79,808.70 crore.

Strides Pharma JV gets approval for anthelmintic tablets
Strides Pharma JV gets approval for anthelmintic tablets

Strides Pharma JV gets approval for anthelmintic tablets

Nidhi Jani Article rating: 5.0

Strides Pharma Science Limited's 50:50 JV Strides Vivimed has got USFDA approval for Albendazole Tablets on Tuesday. The US market for the said tablets is around US$100mn as per IQVIA MAT data.

KDDL acquires Swiss watch company Estima AG
KDDL acquires Swiss watch company Estima AG

KDDL acquires Swiss watch company Estima AG

Apurva Joshi Article rating: 3.2

The Board of Directors of KDDL Limited has approved the acquisition of Estima AG, a Swiss watch hands manufacturing company through its subsidiaries Pylania SA and special purpose vehicle Kamla International Holdings SA.

RSS
First27622763276427652767276927702771Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR